In rare instances, children with a recent history of Sars-CoV2 infection develop a novel immunodysregulation syndrome called multisystem inflammatory syndrome in children or MIS-C. In this study, we set out to investigate the immunopathology of MIS-C and compared this to the hyperinflammatory disease associated with severe SARS-CoV2 infection in adults. Analyzing biomarkers of organ damage, we established that MIS-C does not result in respiratory epithelial damage but is associated with vascular endothelitis and gastrointestinal epithelial cell injury. We observed a strong humoral response against Sars-CoV2 in MIS-C patients, including B cell population expansion and a convalescent antibody repertoire. Measuring cytokine responses, innate i...
We studied SARS-CoV-2-specific T cell responses in 22 subacute MIS-C children enrolled in 2021 and 2...
International audienceMultisystem inflammatory syndrome in children (MIS-C) is a delayed and severe ...
Background: SARS-CoV-2 occurs in the majority of children as COVID-19, without symptoms or with a pa...
In rare instances, pediatric SARS-CoV-2 infection results in a novel immunodysregulation syndrome te...
Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening disease occurring severa...
Posté sur bioRxiv le 23/02/2021SARS-CoV-2 infection in children is generally milder than in adults, ...
Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious complica...
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) presents with inflammation and pat...
SARS-CoV-2 infection in children is generally milder than in adults, yet a proportion of cases resul...
Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious complica...
We studied SARS-CoV-2-specific T cell responses in 22 subacute MIS-C children enrolled in 2021 and 2...
International audienceMultisystem inflammatory syndrome in children (MIS-C) is a delayed and severe ...
Background: SARS-CoV-2 occurs in the majority of children as COVID-19, without symptoms or with a pa...
In rare instances, pediatric SARS-CoV-2 infection results in a novel immunodysregulation syndrome te...
Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening disease occurring severa...
Posté sur bioRxiv le 23/02/2021SARS-CoV-2 infection in children is generally milder than in adults, ...
Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious complica...
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) presents with inflammation and pat...
SARS-CoV-2 infection in children is generally milder than in adults, yet a proportion of cases resul...
Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious complica...
We studied SARS-CoV-2-specific T cell responses in 22 subacute MIS-C children enrolled in 2021 and 2...
International audienceMultisystem inflammatory syndrome in children (MIS-C) is a delayed and severe ...
Background: SARS-CoV-2 occurs in the majority of children as COVID-19, without symptoms or with a pa...